Literature DB >> 16039816

Clinical efficacy of 5-fluorouracil (5-FU) topical cream for treatment of cholesteatoma.

Haruo Takahashi1, Kazuo Funabiki, Seishi Hasebe, Tomomi Fukuda-Yamamoto, Satoru Kaieda, Tetsu Iwanaga, Hidetaka Kumagami, Kenji Takasaki.   

Abstract

OBJECTIVE: In order to clarify clinical efficacy of commercially available 5-fluorouracil (5-FU) topical cream, a clinical study was conducted.
METHODS: Two to three cubic millimetres of 5-FU topical cream (Kyowa, Roche) was applied on 50 cases of various types of cholesteatoma (50 patients) two to five times with the interval of 2 weeks, and its clinical efficacy was evaluated by the criteria we developed.
RESULTS: In total, 59% of the cholesteatomas showed good effect, 29% of them showed fair effect, and the effect was poor in the remaining 12%. It was particularly effective in cholesteatomas in the EAC, attic cholesteatomas with an aerated mastoid, and in recurrent-type cholesteatomas.
CONCLUSION: 5-FU topical cream appeared effective for the treatment of cholesteatomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039816     DOI: 10.1016/j.anl.2005.05.015

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  5 in total

1.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

2.  The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil.

Authors:  Youssef W Naguib; Amit Kumar; Zhengrong Cui
Journal:  Acta Pharm Sin B       Date:  2014-02-01       Impact factor: 11.413

3.  Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.

Authors:  Matthias Schürmann; Felix Oppel; Senyao Shao; Verena Volland-Thurn; Christian Kaltschmidt; Barbara Kaltschmidt; Lars-Uwe Scholtz; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

4.  Inhibitory effect of mesna and 5-fluorouracil on propylene glycol-induced cholesteatoma in rats.

Authors:  Numan Kokten; Ozan Tuysuz; Tulay Zenginkinet; Fatih Mehmet Hanege; Mahmut Tayyar Kalcioglu
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-10       Impact factor: 2.124

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.